Skip to content

Exoskeleton and Spinal Cord Injury

Exoskeleton Training After Spinal Cord Injury

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03410550
Acronym
EXTra-SCI
Enrollment
20
Registered
2018-01-25
Start date
2018-07-01
Completion date
2021-12-30
Last updated
2022-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal Cord Injuries

Brief summary

The purpose of the current study is to investigate the effects of powered exoskeleton (EKSO) on cardiovascular performance as measured by resting blood pressure and heart rate, peak oxygen consumption during walking, energy expenditure, whole and regional body composition assessments. The effects of exoskeleton training on walking kinematics including stand-up time, walking time, distance covered and speed of walking will also be evaluated.

Detailed description

Powered exoskeletons using robotic suits have recently been introduced for the rehabilitation of persons with spinal cord injury (SCI). Exoskeletons offer a unique opportunity for persons with SCI to experience standing and walking at a low metabolic cost. Evidence suggested that exoskeleton assisted walking can decrease spasticity and improve bowel movement. Training may also improve the level of physical activity as well as psychological parameters that are likely to interfere with rehabilitation outcomes. Previous studies reported that a frequency of 2-3 times per week or more for 1-2 hours may be beneficial in the rehabilitation of persons with SCI. Using exoskeletal-assisted walking to improve the level of physical activity may be appealing to persons with SCI. Exoskeleton training for 12 weeks may enhance energy expenditure, parameters of physical activity and result only on modest effects on both cardiovascular and body composition parameters. In other words, persons with tetraplegia may have greater cardiovascular and body composition adaptations compared to persons with paraplegia. Twenty subjects will participate in a powered exoskeleton (EKSO) for one or twice a week for 12 weeks. The program will involve walking with the robotic suits for 1 hour for persons with complete (n=10) and persons with incomplete (n=10) SCI.

Interventions

Twenty subjects will participate in a powered exoskeleton (EKSO) for one or twice a week for 12 weeks. The program will involve walking with the robotic suits for 1 hour for persons with complete (n=10) and persons with incomplete (n=10).

Sponsors

McGuire Research Institute
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Twenty subjects will participate in a powered exoskeleton (EKSO) for one or twice a week for 12 weeks. The program will involve walking with the robotic suits for 1 hour for persons with complete (n=10) and persons with incomplete (n=10) SCI.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. A written clearance by the medical doctor . 2. Participants will have to be 1 year post-injury with any level of injury. 3. All participants will be between 18-70 years old, men/women,

Exclusion criteria

1. Participants with body weight greater than 220 lbs 2. Whole body T-scores less than -2.5 standard deviation will result in elimination from the program. 3. Hip width, upper leg length and lower leg length that do not fit in the robotic suit. 4. Previous unhealed fracture in both lower or upper extremities 5. Leg length discrepancy that is unlikely to be managed by having shoe inserts 6. High resting blood pressure greater than 130/80 mmHg 7. Sudden drop in blood pressure by 20 mmHg especially in persons with tetraplegia. 8. Medical conditions prior enrollment similar to cardiovascular disease, uncontrolled type II diabetes mellitus, uncontrolled hypertension, and those on insulin, pressures sores stage 2 or greater, or urinary tract infection or symptoms. 9. Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Blood Pressure (mmHg)12 weeksResting blood pressure and post-exercise blood pressure will be measured every visit.
Walking time (minutes)12 weeksThe robotic unit will measure standing up time, walking time and walking distance for every visit.
Oxygen uptake (l/min)12 weeksOxygen uptake will be measured during sitting, standing and walking at the beginning and at the end of the training program.
Body Composition (kg)12 weeksBody composition using dual energy x-ray absorptiometry anthropometrics' will be measured during sitting, standing and walking at the beginning and at the end of the training program.

Secondary

MeasureTime frameDescription
Six minute-walk Test (meter)12 weeksThe test will competed at the beginning and at the end of study to measure distance.
10 meter walk Test (m/sec)12 weeksThe test will competed at the beginning and at the end of study to measure speed.
Walking Index for Spinal Cord Injury II (WISCI II)12 weeksThe test will competed at the beginning and at the end of study
Electromyography (EMG) activity of 6 muscle groups (mV)12 weeksThe test will competed at the beginning and at the end of study
Mitochondrial health using near infra-red spectroscopy (seconds)12 weeksThe test will competed at the beginning and at the end of study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026